Copper Peptide AHK-Cu vs Oligopeptide-1
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Tripeptide-3, Ala-His-Lys Copper
AHK-Cu is a synthetic copper-bound tripeptide, alanine-histidine-lysine complexed with a copper ion, engineered mainly for hair and scalp products. It is the lesser-known sibling of the naturally occurring GHK-Cu copper peptide, designed in the lab specifically to push hair follicles to keep growing. It is a cosmetic and research ingredient, not an approved hair-loss drug, and its evidence is essentially limited to one notable lab study.
Also: sh-Oligopeptide-1, rh-Oligopeptide-1
sh-Oligopeptide-1 is the cosmetic ingredient name for recombinant human epidermal growth factor (EGF), a 53-amino-acid protein your skin uses to tell cells to divide and repair. It shows up in 'EGF serums' aimed at wrinkles, texture and post-procedure recovery. It is a cosmetic ingredient in skincare, not an FDA-approved drug for skin aging, and while there are a fair number of small human studies, very few are properly controlled.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
- Oligopeptide-1 has stronger research evidence (Human Trials) compared to Copper Peptide AHK-Cu (Limited Research).
Detailed Comparison
| Attribute | Copper Peptide AHK-Cu | Oligopeptide-1 |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Copper peptides like AHK-Cu are thought to act as carriers and signals for copper, a metal involved in tissue repair, blood vessel growth and collagen remodeling. In hair, the proposed action centers on dermal papilla cells, the control hub at the base of each follicle that orchestrates the growth cycle. AHK-Cu is hypothesized to keep those cells alive and dividing longer, partly by shifting the balance of survival proteins (more Bcl-2, less Bax) so follicle cells are less likely to enter programmed cell death, which would extend the active growth phase. These are mechanisms observed in cells and isolated follicles, not proven outcomes in people growing hair. | EGF binds the EGF receptor on keratinocytes and fibroblasts and switches on growth and repair signaling: cell division, migration, and production of matrix proteins. That is why it has been studied for wound healing, and why cosmetic brands use it to support skin renewal. Two practical problems: EGF is a fairly large protein, so getting it through intact skin is hard (which is why many studies pair it with microneedling or lasers), and it is fragile, so how much stays active in a jar at room temperature is a fair question. The same growth-promoting signal is also the source of the safety debate: EGF receptor signaling drives several cancers, so the concern is not that EGF causes cancer, but whether it could encourage abnormal cells that are already there. |
| Common Dosing | Limited community data available See research protocols | Low parts-per-million concentration in a serum Once or twice daily |
| Administration | Topical (scalp serums, solutions) | Topical (serums, ampoules, creams); sometimes combined with microneedling in clinic |
| Typical Duration | 3-6 months for visible results | Studies typically ran 4 to 12 weeks |
| Best Time to Take | Morning or as directed | Evening skincare routine, or right after an in-clinic procedure |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The science here is real but narrow. The anchor study is Pyo and colleagues, published in Archives of Pharmacal Research in 2007, which tested AHK-Cu on human hair follicles and dermal papilla cells outside the body. At very low concentrations it significantly lengthened isolated human hair follicles and increased dermal papilla cell proliferation, while reducing apoptosis markers, and notably the effect followed a tight dose-response curve where higher concentrations stopped working. That is genuine peer-reviewed evidence for a biological effect. What does not exist is the part people actually want: randomized controlled human trials showing that applying AHK-Cu to a scalp regrows hair or thickens it in living people. So the honest read is that AHK-Cu has a plausible mechanism and one credible ex vivo and in vitro study behind it, but its real-world hair-growth benefit in humans is unproven, and most consumer claims extrapolate well beyond what that single study supports. | A 2021 systematic review in the Journal of Cutaneous and Aesthetic Surgery (Miller-Kobisher and colleagues) found 49 articles on rhEGF for skin, including 23 aesthetic studies. Most reported less wrinkling, better hydration and elasticity, and the strongest data were for pigmentation after lasers and melasma. But the authors admit many trials were uncontrolled or not randomized, samples were often 8 to 40 people, and they called for proper controlled trials. Adverse effects were mild and short-lived. The review did not address cancer risk at all, which is a real gap. Several of the better-known growth-factor trials tested multi-factor mixtures, not EGF alone. On safety: there is no human evidence that cosmetic EGF causes skin cancer, and in vitro tests of growth-factor cosmetics on melanoma cells were reassuring, but long-term studies in healthy skin do not exist. Sensible caution: people with a history of skin cancer, many atypical moles, or active psoriasis should talk to a dermatologist before using it. Bottom line: plausible and widely used, modest and mostly low-quality efficacy data, and an unresolved theoretical safety question. |
Frequently Asked Questions: Copper Peptide AHK-Cu vs Oligopeptide-1
What is the difference between Copper Peptide AHK-Cu and Oligopeptide-1?
Copper Peptide AHK-Cu is a skin & hair peptide that ahk-cu is a synthetic copper-bound tripeptide, alanine-histidine-lysine complexed with a copper ion, engineered mainly for hair and scalp products. it is the lesser-known sibling of the naturally occurring ghk-cu copper peptide, designed in the lab specifically to push hair follicles to keep growing. it is a cosmetic and research ingredient, not an approved hair-loss drug, and its evidence is essentially limited to one notable lab study. Oligopeptide-1 is a skin & hair peptide that sh-oligopeptide-1 is the cosmetic ingredient name for recombinant human epidermal growth factor (egf), a 53-amino-acid protein your skin uses to tell cells to divide and repair. it shows up in 'egf serums' aimed at wrinkles, texture and post-procedure recovery. it is a cosmetic ingredient in skincare, not an fda-approved drug for skin aging, and while there are a fair number of small human studies, very few are properly controlled. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Copper Peptide AHK-Cu or Oligopeptide-1?
Neither is universally "better" - the choice depends on your specific goals. Copper Peptide AHK-Cu is typically used for skin & hair purposes, while Oligopeptide-1 is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Copper Peptide AHK-Cu and Oligopeptide-1 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Copper Peptide AHK-Cu and Oligopeptide-1 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.